Glaxo asthma drug Advair's patent invalid, rules German court - Telegraph

Links shared publicly online about this topic.

  • 1,154
    total visits

Glaxo asthma drug Advair's patent invalid, rules German court - Telegraph

telegraph.co.uk —

A key patent on GlaxoSmithKline's top-selling asthma drug, Advair, has been deemed invalid by a German court, potentially paving the way for generic competition.

View full resource at telegraph.co.uk

Tags: Asthma, Asthma Medication, COPD Medication, Drug, Advair

  • Share

Most Recently Shared on May 20, 2010 at 11:00 pm By:

hrana Hisham Rana, MD

News: Glaxo asthma drug Advair's patent invalid, rules German court http://bit.ly/9dLsm3 - Good for generics. #health #pharma

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

Michael Blaiss, MD Michael Blaiss, MD

Advertisement